Safety and Efficacy of Pimavanserin in Adults With Parkinson's Disease and Depression

NCT03482882 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

47

Enrollment

INDUSTRY

Sponsor class

Conditions

Treatment of Depression in Adults With Parkinson's Disease (PD)

Interventions

DRUG: Pimavanserin

Sponsor

ACADIA Pharmaceuticals Inc.